<div id="readability-page-1"><p>Quantum-Si Incorporated (NASDAQ:QSI - Get Free Report) insider John Vieceli sold 21,927 shares of the stock in a transaction dated Monday, December 22nd. The stock was sold at an average price of $1.28, for a total transaction of $28,066.56. Following the sale, the insider directly owned 800,973 shares in the company, valued at approximately $1,025,245.44. The trade was a 2.66% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is available at the SEC website.</p><h2>Quantum-Si Stock Performance</h2><ul><li>Penny Stock Quantum-Si Incorporated Readies For Lift-Off</li></ul><p>Shares of QSI stock remained flat at $1.27 during trading hours on Monday. The stock had a trading volume of 5,071,186 shares, compared to its average volume of 3,958,795. Quantum-Si Incorporated has a twelve month low of $0.95 and a twelve month high of $5.77. The company has a market capitalization of $273.67 million, a price-to-earnings ratio of -1.90 and a beta of 2.97. The business's fifty day moving average price is $1.66 and its 200 day moving average price is $1.58. </p><p>Quantum-Si (NASDAQ:QSI - Get Free Report) last released its quarterly earnings results on Wednesday, November 5th. The company reported ($0.17) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.17). Quantum-Si had a negative net margin of 3,677.97% and a negative return on equity of 47.90%. The firm had revenue of $0.55 million for the quarter, compared to analysts' expectations of $0.60 million.  On average, equities analysts predict that  Quantum-Si Incorporated will post -0.65 earnings per share for the current year. </p><h2>Analysts Set New Price Targets</h2><p>A number of equities analysts have weighed in on QSI shares. Weiss Ratings  reissued a &#34;sell (e+)&#34; rating on shares of Quantum-Si in a research note on Monday, December 8th. Canaccord Genuity Group reduced their price target on Quantum-Si from $2.00 to $1.50 and set a &#34;hold&#34; rating on the stock in a report on Monday. Two research analysts have rated the stock with a Buy rating, one  has given a Hold rating and one  has given a Sell rating to the company's stock. According to MarketBeat, the company  has an average rating of &#34;Hold&#34; and a consensus price target of $3.60.</p><p><b>Check Out Our Latest Analysis on QSI</b></p><h2>Hedge Funds Weigh In On Quantum-Si</h2><p>A number of hedge funds have recently modified their holdings of QSI. Prudential Financial Inc. acquired a new position in  Quantum-Si in the second quarter valued at about $25,000.  JTC Employer Solutions Trustee Ltd purchased a new stake in shares of  Quantum-Si in the 2nd quarter valued at approximately $26,000.  Cerity Partners LLC acquired a new position in shares of  Quantum-Si in the 2nd quarter worth approximately $29,000.  Wolverine Asset Management LLC lifted its holdings in shares of  Quantum-Si by 140.0% in the 2nd quarter. Wolverine Asset Management LLC now owns 16,501 shares of the company's stock worth $32,000 after acquiring an additional 9,626 shares during the last quarter.  Finally, Capital Investment Advisory Services LLC boosted its position in shares of  Quantum-Si by 100.0% during the 3rd quarter. Capital Investment Advisory Services LLC now owns 20,000 shares of the company's stock worth $28,000 after purchasing an additional 10,000 shares during the period. 39.90% of the stock is currently owned by hedge funds and other institutional investors. </p><h2>About Quantum-Si</h2> (Get Free Report)<p>Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods. </p><p>Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.</p><h2>See Also</h2><ul><li>Five stocks we like better than Quantum-Si</li><li>Nvidia CEO Issues Bold Tesla Call</li><li>How Long Will $1M Last in Retirement?</li><li>[No Brainer Gold Play]: “Show me a better investment.”</li><li>Protect Your Bank Account with THESE 4 Simple Steps</li><li>End of America update</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UVNJ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UVNJ"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Quantum-Si Right Now?</h2><p>Before you consider Quantum-Si, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantum-Si wasn't on the list.</p><p>While Quantum-Si currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Quantum-Si insider John Vieceli sold 21,927 shares at $1.28 each, totaling $28,066.56, reducing his ownership by 2.66%. Post-sale, he holds 800,973 shares valued at $1,025,245.44. The transaction was disclosed to the SEC. Quantum-Si's stock remained flat at $1.27 with a market cap of $273.67 million. Analysts have mixed ratings on the stock, with a consensus price target of $3.60. Hedge funds have been adjusting their holdings in the company.</p>

Insider Selling: Quantum-Si (NASDAQ:QSI) Insider Sells 21,927 Shares of Stock